- Financial Stocks Rally as Jefferies Turns Bullish Through 2021 (Bloomberg)
- Opinion: Put bank stocks in the ‘buy’ pile if you think a coronavirus vaccine will help mend the economy (MarketWatch)
- Pfizer’s Final Analysis Shows Covid Vaccine is 95% Effective (Barron’s)
- The MAX Jet Is Back. It’s Good for More Stocks Than Boeing. (Barron’s)
- U.S. housing starts beat expectations in October (Reuters)
- Apple to Cut App Store Fees in Half for Most Developers (Yahoo! Finance)
- Hospitals may limit access to Eli Lilly COVID-19 treatment (New York Post)
- FDA Gives Nod To First COVID-19 At-Home Rapid Test (Benzinga)
- Rupert Murdoch’s News Corp Bids for Simon & Schuster (New York Times)
- Disappearing Tweets? Twitter Now Has a Feature for That (New York Times)
- Warren Buffett is Hiding Something Big (Street Insider)
- ‘The Squad’ pushes Biden to cancel student debt — here’s how they’d personally benefit (Fox Business)
- Tire Maker Michelin Could Get a Lift From More Drivers (Barron’s)
- How Bad Is Amazon Pharmacy for CVS and Walgreens? (Barron’s)
- Here’s why stocks can climb 15% next year, according to JPMorgan’s strategists (MarketWatch)
- ‘Keep the faith, trust the recovery’ — Morgan Stanley raises its S&P 500 target but says it won’t be a smooth ride (MarketWatch)
- The ECB May Loosen Its Dividend Ban, so Eurozone Banks Should Narrow the Gap With UBS, Goldman Sachs Says (Barron’s)
- Fund managers have hopped on the rotation-to-value trade, latest Bank of America survey shows (MarketWatch)
- Japan’s exports nearly back at pre-COVID levels (MarketWatch)
- U.S. Retail Sales Climbed at a Slower Pace in October (Wall Street Journal)
- Moderna and Pfizer Are Reinventing Vaccines, Starting With Covid (Wall Street Journal)
- Mortgage demand from homebuyers surges after election pause (CNBC)
- JPMorgan’s Jamie Dimon Says Congress Is Being ‘Childish’ on Stimulus (Bloomberg)
- Goldman Sachs says commodities poised for bull market (Reuters)
- Pfizer says it will seek U.S. emergency-use authorization within days for coronavirus vaccine (MarketWatch)